UCB's Global Corporate Website
Welcome to UCB in the United States
  • Healthcare Professionals
  • Patients
  • Investors
  • Newsroom

    No results

    Press Releases

    UCB Comes to Agreement with U.S. Government to Lower the Cost of Medicine and Strengthen U.S.…

    Read More

    Axios Names UCB a Winner of the Metro Atlanta Top Workplaces 2026 Award

    Read More

    Epilepsia Open publishes results of post hoc data analysis of FINTEPLA® (fenfluramine) in patients…

    Read More

    UCB Awards Annual Myasthenia Gravis Scholarships to 15 Individuals Impacted by MG in the U.S.

    Read More

    UCB Launches Career-Advancing Scholarship Program for Adults Living with Hidradenitis Suppurativa…

    Read More

    BIMZELX® (bimekizumab-bkzx) demonstrates superior efficacy over SKYRIZI® (risankizumab-rzaa) in…

    Read More

    UCB Stories

    UCB Announces Publication of Data in Brain Communications Demonstrating Positive Impact of KYGEVVI®…

    Read More

    Supporting Families During Dravet Syndrome Awareness Month: A look into Camp Small Steps

    Read More

    Running Toward Relief: How Cassie is Reclaiming Her Life With Psoriatic Arthritis

    Read More

    UCB Issues Voluntary Recall of Select Lots of CIMZIA® Pre-Filled Syringes (PFS) in the United States

    Read More

    UCB’s Catherine Rives and Alexandria Harrold Recognized by Healthcare Businesswomen’s Association…

    Read More

    Evolving Expectations in Immunologic Disease: Our work with those living with immune-mediated…

    Read More

    For More Information